XML 27 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments
 12 Months Ended
Dec. 31, 2020
Investments, All Other Investments [Abstract]  
Financial Instruments FINANCIAL INSTRUMENTS
The carrying amounts of our cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short maturity of these instruments and are classified as Level 1 in the fair value hierarchy. The carrying value of bank debt approximates fair value, as the interest rate on the bank debt is variable and approximates current market rates.  As a result, the fair value measurement of our bank debt is classified as Level 2 in the fair value hierarchy.
Concentrations of Credit Risk - Financial instruments that may subject us to concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly-rated financial institutions, limiting the amount of credit exposure with any one financial institution. Our client base consists of large numbers of geographically diverse customers dispersed throughout the United States; thus, concentration of credit risk with respect to accounts receivable is not significant.
Available-For-Sale Debt Securities - Available-for-sale debt securities consist primarily of corporate and municipal bonds and US treasury bills. The net par values of these securities total $24.9 million and $58.9 million at December 31, 2020 and 2019, respectively. The bonds have maturity dates or callable dates ranging from January 2021 through November 2024, and are included in “Funds held for clients — current” in the accompanying Consolidated Balance Sheets based on our intent and ability to sell these investments at any time under favorable conditions.
At December 31, 2020, unrealized losses on the securities totaling approximately $0.1 million have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.
The following table summarizes our bond activity for the years ended December 31, 2020 and 2019 (in thousands):
20202019
Fair value at January 1$60,659 $56,556 
Purchases3,447 27,216 
Sales(22,078)(1,686)
Maturities and calls(15,409)(22,272)
Decrease in bond premium(857)(460)
Fair market value adjustment(54)1,305 
Fair value at December 31$25,708 $60,659 
In addition to the available-for-sale securities discussed above, we also held certified deposits and other depository assets in the amount of $2.5 million at December 31, 2019. We did not have any depository items at December 31, 2020.
Interest Rate Swaps - We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under the 2018 credit facility, or the forecasted acquisition of such liability. Under these interest rate swap contracts, we receive cash flows from counterparties at variable rates based on LIBOR and pay the counterparties a fixed rate. To mitigate counterparty credit risk, we only enter into contracts with selected major financial institutions with investment grade ratings and continually assess their creditworthiness. There are no credit risk-related contingent features in our interest rate swaps nor do the swaps contain provisions under which we would be required to post collateral. We do not purchase or hold any derivative instruments for trading or speculative purposes.
The designation of a derivative instrument as a hedge and its ability to meet the hedge accounting criteria determine how we reflect the change in fair value of the derivative instrument. A derivative qualifies for hedge accounting
treatment if, at inception, it meets defined correlation and effectiveness criteria. These criteria require that the anticipated cash flows and/or changes in fair value of the hedging instrument substantially offset those of the position being hedged.
We had no fair value hedging instruments at December 31, 2020 or 2019. Our interest rate swaps are designated as cash flow hedges. Accordingly, the interest rate swaps are recorded as either an asset or liability in the accompanying Consolidated Balance Sheets at fair value. The mark-to-market gains or losses on the swaps are deferred and included as a component of accumulated other comprehensive loss (“AOCL”), net of tax, to the extent the hedge is determined to be effective, and reclassified to interest expense in the same period during which the hedged transaction affects earnings. The interest rate swaps are assessed for effectiveness and continued qualification for hedge accounting on a quarterly basis. For the years ended December 31, 2020 and 2019, the interest rate swaps were deemed to be highly effective.
The following table summarizes our outstanding interest rate swaps and their classification in the accompanying Consolidated Balance Sheets at December 31, 2020 and 2019 (in thousands). Refer to Note 7, Fair Value Measurements, to the accompanying consolidated financial statements for additional disclosures regarding fair value measurements.
December 31, 2020
Notional
Amount		Fair
Value		Balance Sheet Location
Interest rate swap$10,000 $(13)Other current liability
Interest rate swaps$85,000 $(2,552)Other non-current liabilities
December 31, 2019
Notional
Amount		Fair
Value		Balance Sheet Location
Interest rate swaps$45,000 $(591)Other non-current liabilities
Interest rate swap$25,000 $66 Other current assets
During 2020, we entered into a new 5-year interest rate swap with a notional value of $50.0 million and terminated one interest rate swap with a notional value of $25.0 million. As of December 31, 2020, we have four interest rate swaps outstanding. Under the terms of the interest rate swaps, we pay interest at a fixed rate of interest plus applicable margin as stated in the agreement, and receive interest that varies with the one-month LIBOR. The notional value, fixed rate of interest and expiration date of each interest rate swap as of December 31, 2020 is (i) $10 million – 1.120% - February, 2021, (ii) $20 million – 1.770% - May, 2022, (iii) $15 million – 2.640% - June, 2023 and (iv) $50.0 million - 0.885% - April, 2025.
During the next twelve months, the amount of the December 31, 2020 AOCL balance that will be reclassified to earnings is expected to be immaterial. The following table summarizes the effects of the interest rate swap on our accompanying Consolidated Statements of Comprehensive Income for the years ended December 31, 2020 and 2019 (in thousands):
Loss recognized in
AOCL, net of tax		(Loss) Gain reclassified from
AOCL into expense
Twelve Months Ended December 31,Twelve Months Ended December 31,Location
2020201920202019
Interest rate swaps$(1,525)$(1,222)$(974)$399 Interest expense